Download presentation
Presentation is loading. Please wait.
Published byAdela Anderson Modified over 6 years ago
1
Table 1. Number of reported confirmed LGV cases, EU/EEA, 2010–2014
Country 2010 2011 2012 2013 2014 Austria - Belgium 22 21 23 48 60 Bulgaria Croatia Cyprus Czech Republic 1 6 9 8 20 Denmark 29 24 32 36 Estonia Finland 3 5 7 2 France 184 191 197 327 377 Germany Greece Hungary Iceland Ireland 35 Italy 11 27 12 Latvia Liechtenstein Lithuania Luxembourg Malta Netherlands 66 70 190 112 172 Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden United Kingdom 428 408 402 512 678 EU/EEA total 728 739 881 1075 1416 ASR: age-standardised rate, C: case-based Source: Country reports Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Lymphogranuloma venereum. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
2
Figure 1. Age distribution of reported confirmed LGV cases, EU/EEA, 2014
Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Lymphogranuloma venereum. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
3
Figure 2. Number of reported confirmed LGV cases for selected EU/EEA Member States, 2005–2014
Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Lymphogranuloma venereum. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
4
Table. LGV, surveillance systems overview, 2014
Surveillance Data reported by Case definition used Country Data source L P H O Belgium BE-STD V Se . C N Y Not specified/unknown Croatia HR-CNIPH Cp Co EU-2012 Cyprus CY-NOTIFIED_DISEASES EU-2008 Czech Republic CZ-STD A Other Denmark DK-LAB Estonia EE-NAKIS Finland FI-NIDR France FR-STI EU Case Definition (legacy/deprecated) Hungary HU-STD SURVEILLANCE Iceland IS-SUBJECT_TO_REGISTRATION Ireland IE-CIDR Italy IT-COA ISS- STI clin Latvia LV-BSN Luxembourg LU-SYSTEM1 Malta MT-DISEASE_SURVEILLANCE Netherlands NL-STI Norway NO-MSIS_CHLAMYDIA) Poland PL-NATIONAL_SURVEILLANCE Slovenia SI-SPOSUR Sweden SE-SMINET United Kingdom UK-GUM-COM-LAB Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report LGV. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.